drugset / Trial / NCT04712266
A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes
RandomizedCrossoverOpen-labelTreatment
Summary
This is a single center, double-blind, randomized trial in subjects with type 1 diabetes mellitus applying an adaptive design approach.
Timeline
- Start
- 2020-09-15
- Primary completion
- 2020-12-15
- Completion
- 2021-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glucagon | Peptide | — | Intravenous |
| Subject | Insulin | Protein / enzyme biologic | — | Intravenous |